Endometrial thickness and ovarian cysts as measured by ultrasound in asymptomatic postmenopausal breast cancer patients on various adjuvant treatments including tamoxifen

Anticancer Research

Volumn 17, Issue 5 B, 1997, Pages 3821-3824

  Lindahl, Bengt ^a   Andolf, Ellika ^a   Ingvar, Christian ^a   Liedman, Ragner ^a   Ranstam, Jonas ^a   Willén, Roger ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adjuvant treatments; Breast cancer; Endometrium; Ovarian cysts; Tamoxifen; Ultrasound

Indexed keywords

CYTOSTATIC AGENT; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURGERY; CLINICAL EXAMINATION; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT; OVARY CYST; POSTMENOPAUSE; PRIORITY JOURNAL; ULTRASOUND;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; OVARIAN CYSTS; POSTMENOPAUSE; PROSPECTIVE STUDIES; TAMOXIFEN;

EID: 0031467845     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cancer incidence in Sweden 1993. The National Board of Health and Wellfare. Stockholm, Sweden, 1996.
2. Whittemore AS: Characteristics relating to ovarian cancer risk: Implications for prevention and detection. Gynecologic Oncology 55: S15-S19,1994.
3. Ford D, Easton DF: The genetics of breast and ovarian cancer. Br J Cancer 72: 805-812, 1995.
4. Adami HO, Kruesmo UB, Bergkvist L, Persson I and Pettersson B: On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study. Br J Cancer 55: 77-80, 1987.
5. Hall JM, Lee MK, Newman B, Morrow JE, Andersson LA, Huey B and King M-C: Linkage of early onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689, 1990.
6. Easton EF, Ford D, Bishop DT and the Breast Cancer Linkage Consortium: Breast and Ovarian Cancer incidence in BRCA1-mutation Am J Hum Genet 56: 265-271, 1995.
7. Ford D, Easton DF: The genetics of breast and ovarian cancer. Br J Cancer 72: 805-812, 1995.
8. Killackey MA, Hakes TB, Pierce VK: Endometrial adenocarcinoma in breast cancer patients receiving tamoxifen. Cancer 69: 237-238, 1985.
9. Fornander T, Rutquist LE, Cedermark B et al: Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1: 117-120, 1989.
10. Breast cancer Trials Committee, Scottish Cancer Trials Office: Adjuvant Tamoxifen in the management of operable breast cancer: The Scottish Trial. Lancet 2: 171-175, 1987.
11. Ribeiro G, Swindell R: The Christie Hospital adjuvant tamoxifen trial-Status at 10 years. Br J Cancer 57: 601-603, 1988.
12. Nolvadex Adjuvant Trial Organisation: Controlled trial of tamoxifen as a single adjuvant agent in management of early breast cancer. Analysis of eight years by the Nolvadex Adjuvant Trial Organisation. Br J Cancer 57: 608-611,1988.
13. Andolf E, Dahlander K, Aspenberg P: Ultrasonic thickness of the endometrium correlated to body weight in asymptomatic postmenopausal women. Obstetrics Gynecology 82: 936-940, 1993.
14. Karlsson B, Granberg S et al: Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding- A Nordic multicentcr study. Am J Obstet Gynecol 172: 1488-1494, 1995.
15. Gull B, Karlsson B, Milsom I, Wikland M, Granberg S: Transvaginal sonography of the endometrium in a representative sample of postmenopausal women. Ultrasound Obstet Gynecol 7: 322-327, 1996.
16. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T: Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81: 660-664, 1993.
17. Cohen 1, Rosen DJD, Shapira J, Cordoba M, Gilboa S, Altaras MM, Yigael D, Beyth Y: Endometrial changes with tamoxifen: Comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecologic Oncology 52: 185-190, 1994
18. Rayter Z, Gazet J-C, Shepherd J, Trott PA, Fisher C, Svensson WE, Ford HT, A, Hern R: Gynaecological cytology and pelvic ultrasonography in patients with breast cancer taking tamoxifen compared with controls. European J Surgical Oncology 20: 134-140, 1994.
19. Uziely B, Lewni A, Brufman G, Dorembus D, Shlomo M-Y: The effect of tamoxifen on the endometrium. Breast Cancer Research and Treatment 26: 101-105, 1993.
20. Cohen 1, Rosen DJD, Tepper R, Cordoba M, Shapira Y, Altaras MM, Yigael D, Beyt Y: Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 5: 275-280, 1993.
21. Cohen I, Rosen DJD, Tepper R, Cordoba M, Shapira Y, Altaras MM, Yigael D, Beyt Y: Continous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies. Gynecologic Oncology 55: 138-143, 1994.
22. Bornstein J, Auslender R, Pascal B, Gutterman E, Isakov D, Abramovici H: Diagnostic pitfalls of ulrasonographic uterine screening in women treated with tamoxifen. J Reprod Med 39: 674-678, 1994.
23. Campbell S, Bhan V, Royston P, Whitehead MI, Collins WP: Transabdominal ultrasound screening for early ovarian cancer. BMJ 299: 1363-1367, 1989.
24. Levine D, Gosink BB, Wolf SI, Feldesman MR, Pretorius DH: Simple adnexal cysts: The natural history in postmenopausal women. Radiology 184: 653-659, 1992.
25. Armitage P, Berry G: Statistical Methods in Medical Research. Blackwell Scientific Publications. Oxford 1987, UK. pp115.